p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer

Ravaioli, A.; Monti, F.; Regan, M. M.; Maffini, F.; Mastropasqua, M. G.; Spataro, V.; Castiglione-Gertsch, Monica; Panzini, I.; Gianni, L.; Goldhirsch, A.; Coates, A.; Price, K. N.; Gusterson, B. A.; Viale, G. (2008). p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer. Annals of oncology, 19(4), pp. 660-668. Oxford University Press 10.1093/annonc/mdm547

[img]
Preview
Text
mdm547.pdf - Published Version
Available under License Publisher holds Copyright.

Download (228kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Castiglione, Monica

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0923-7534

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

01 Oct 2018 12:21

Last Modified:

05 Dec 2022 15:13

Publisher DOI:

10.1093/annonc/mdm547

BORIS DOI:

10.7892/boris.115576

URI:

https://boris.unibe.ch/id/eprint/115576

Actions (login required)

Edit item Edit item
Provide Feedback